Allspring Global Investments
ALPN

Allspring Global Investments’s Alpine Immune Sciences Inc ALPN Stock Holding History

Allspring Global Investments’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-6,414
Closed -$254K – 2560
2024
Q1 		$254K Buy
6,414
+4,926
+331% +$145K ﹤0.01% 1657
2023
Q4 		$28.4K Buy
1,488
+1,312
+745% +$18.2K ﹤0.01% 1936
2023
Q3 		$2.02K Buy
+176
New +$2.17K ﹤0.01% 2713
2023
Q1 		– Sell
-4,453
Closed -$32.7K – 2975
2022
Q4 		$32.7K Sell
4,453
-125,736
-97% -$804K ﹤0.01% 2460
2022
Q3 		$937K Sell
130,189
-6,608
-5% -$54.5K ﹤0.01% 1435
2022
Q2 		$1.16M Buy
136,797
+119,935
+711% +$1.03M ﹤0.01% 1388
2022
Q1 		$151K Buy
16,862
+10,835
+180% +$93.7K ﹤0.01% 2657
2021
Q4 		$83K Buy
+6,027
New +$74.7K ﹤0.01% 2791

Allspring Global Investments's ALPN Position: Q2 2024 in Review

Allspring Global Investments sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 6,414 shares — an estimated $254K sold.

Allspring Global Investments first reported a position in ALPN in Q4 2021 and held it in 8 quarters. The position peaked at $1.16M in Q2 2022. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Allspring Global Investments reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Allspring Global Investments sold 6,414 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $254K.
  • Allspring Global Investments first reported a position in Alpine Immune Sciences Inc in Q4 2021 and held it in 8 quarters.
  • Allspring Global Investments's Alpine Immune Sciences Inc position peaked at $1.16M in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Allspring Global Investments's 13F filing for Q2 2024, filed 26 Jul 2024.